Hylckama Vlieg Johan Van serves as Executive at Kaleido Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Hylckama Vlieg Johan Van has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 28, 2022 involved selling 2,087 shares valued at $3.1K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 28, 2022 | KLDO | $3.1K | Payment | 2,087 | $1.49 | Discretionary |
Hylckama Vlieg Johan Van currently holds 4,620 shares of Kaleido Biosciences, Inc. (KLDO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hylckama Vlieg Johan Van has been a net neutral trader of KLDO stock. They have purchased $0 and sold $0 worth of shares.
Hylckama Vlieg Johan Van's most recent insider trade was on Feb 28, 2022, when they sold 2,087 shares at $1.49 per share.
Get notified when new Form 4 filings are submitted